Clinical Trial Update: The Effect of Interscalene Peripheral Nerve Block With 0.25% Bupivacaine vs 0.125% Bupivacaine on Lung Function [NA]

View source ↗

Summary

A completed University of Utah trial compared interscalene nerve block with 0.25% versus 0.125% bupivacaine to assess effects on lung function in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diaphragm Paralysis

Drugs mentioned

• Bupivacaine (Bupivacaine)

Snippet

Sponsor: University of Utah | Conditions: Diaphragm Paralysis | NA | Status: COMPLETED | Results posted: 2013-12-19